If you have type 2 diabetes, you may be taking a new drug called Invokana (canagliflozin). It was the first in a new class of diabetes drugs to be approved by the U.S. Food and Drug Administration (FDA). Invokana quickly became popular, and since it was approved other sodium-glucose cotransporter-2 (SGLT2) inhibitors have hit the market, all with similar side effects and risks.
Most Common Invokana Side Effects
The most common side effects of Invokana are urogenital infections, including yeast infection in both women and men and urinary tract infection (UTI), and increased urination. In clinical trials, 14% of women and 3.9% of men taking Invokana developed urogenital fungal infections at rates four to six times higher than those taking other diabetes drugs.
Increased urination can lead to low blood pressure upon standing which can cause in dizziness and falls.
Other Side Effects
Invokana was approved in March, 2013. In its first year on the market, there were at least 457 serious adverse event reports. In addition to those listed above, Invokana side effects and injuries can include:
- Diabetic ketoacidosis
- Dehydration and fluid imbalances
- Severe allergic reaction
- Kidney stones
- Kidney impairment
- Kidney failure
- Hypoglycemia
- Abnormally low blood pressure
- Abnormal weight loss
- Heart attack
- Stroke
- Increased LDL cholesterol
Post-Market Studies
When the FDA approved Invokana, it was concerned about certain potential risks to the extent that it required post-market studies of dangers including:
- Cancer
- Pancreatitis
- Liver abnormalities
- Photosensitivity
- Adverse pregnancy outcomes
- Bone fractures
If you believe that your injuries were caused by Invokana, a defective drug attorney can help.
